Table 2.
Quantitative metrics of myocardial uptake
| Chemotherapy regimen | Staging scan | Interim scan | EOT scan | P-value | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R-CHOP | ABVD | Both | R-CHOP | ABVD | Both | R-CHOP | ABVD | Both | R-CHOP | ABVD | Both | |
| SUVmean | 6.77 ± 5.04 | 5.43 ± 2.68 | 6.27 ± 4.29 | 8.44 ± 4.46 | 6.65 ± 3.26 | 7.77 ± 4.07 | 7.03 ± 4.13 | 7.58 ± 4.88 | 7.24 ± 4.33 | 0.627 | 0.895 | 0.607 |
| SUVmax | ||||||||||||
| Septal Region | 9.47 ± 6.76 | 8.15 ± 4.00 | 8.97 ± 5.81 | 11.35 ± 5.67 | 9.32 ± 3.69 | 10.59 ± 5.24 | 10.05 ± 5.94 | 10.44 ± 7.29 | 10.20 ± 6.32 | 0.627 | 0.717 | 0.453 |
| Lateral Region | 10.86 ± 7.30 | 9.43 ± 5.27 | 10.32 ± 6.53 | 13.39 ± 6.44 | 10.41 ± 4.48 | 12.27 ± 5.86 | 11.96 ± 5.99 | 12.67 ± 7.79 | 12.23 ± 6.57 | 0.766 | 0.895 | 0.747 |
| LAD/LCX | 81.73% ± 7.99 | 85.78% ± 8.14 | 83.25% ± 8.12 | 84.30% ± 6.05 | 87.78% ± 4.11 | 85.61% ± 5.58 | 78.75% ± 7.94 | 84.43% ± 10.37 | 80.88% ± 9.15 | 0.041 | 0.459 | 0.167 |
| RCA/LCX | 81.62% ± 10.01 | 84.67% ± 4.82 | 82.77% ± 8.44 | 82.33% ± 7.54 | 86.84% ± 6.59 | 84.02% ± 7.39 | 78.80% ± 11.77 | 81.93% ± 8.67 | 79.97% ± 10.62 | 0.819 | 0.717 | 0.607 |
| SLUR | 80.28% ± 11.09 | 83.95% ± 5.94 | 81.66% ± 9.51 | 83.65% ± 8.22 | 86.38% ± 7.54 | 84.67% ± 7.92 | 78.81% ± 12.13 | 81.23% ± 10.14 | 79.72% ± 11.26 | 0.247 | 0.895 | 0.582 |
Statistically significant correlation coefficients are given in bold